Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Drug Updates

  • Brukinsa Receives Accelerated FDA Approval for Mantle-Cell Lymphoma
  • Ziextenzo Third Biosimilar to Neulasta Approved for Febrile Neutropenia
  • Tecentriq Approved with Chemotherapy for First-Line Treatment of Metastatic NSCLC without EGFR or ALK Mutations
  • FDA Approves Calquence for Adults with CLL or SL
  • Zejula Receives FDA Approval for HRD-Positive Advanced Ovarian Cancer
  • Teva Will Resume Production of Vincristine in Response to Shortage
  • FDA Fast-Tracks Opdivo plus Yervoy Regimen for Treatment of Advanced Liver Cancer
  • FDA Grants Accelerated Approval to Brukinsa for Patients with Mantle-Cell Lymphoma

Results 1 - 3 of 3